Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Determinant Factors of Ceasing Anti-seizure Medication in Infants With Neonatal Seizures: A Single-center Retrospective Study

NCT06211192 is registered in ClinicalTrials.gov with Balikesir University as lead sponsor.

NCT NCT06211192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06211192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Determinant Factors of Ceasing Anti-seizure Medication in Infants With Neonatal Seizures: A Single-center Retrospective Study
Lead sponsor
Balikesir University
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
October 1, 2023
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal seizure